63 related articles for article (PubMed ID: 30290411)
1. Human PAF complexes in endocrine tumors and pancreatic cancer.
Deb S; Ponnusamy MP; Senapati S; Dey P; Batra SK
Expert Rev Endocrinol Metab; 2008 Sep; 3(5):557-565. PubMed ID: 30290411
[TBL] [Abstract][Full Text] [Related]
2. Human RNA polymerase II-associated factor complex: dysregulation in cancer.
Chaudhary K; Deb S; Moniaux N; Ponnusamy MP; Batra SK
Oncogene; 2007 Nov; 26(54):7499-507. PubMed ID: 17599057
[TBL] [Abstract][Full Text] [Related]
3. The human PAF complex coordinates transcription with events downstream of RNA synthesis.
Zhu B; Mandal SS; Pham AD; Zheng Y; Erdjument-Bromage H; Batra SK; Tempst P; Reinberg D
Genes Dev; 2005 Jul; 19(14):1668-73. PubMed ID: 16024656
[TBL] [Abstract][Full Text] [Related]
4. The parafibromin tumor suppressor protein is part of a human Paf1 complex.
Rozenblatt-Rosen O; Hughes CM; Nannepaga SJ; Shanmugam KS; Copeland TD; Guszczynski T; Resau JH; Meyerson M
Mol Cell Biol; 2005 Jan; 25(2):612-20. PubMed ID: 15632063
[TBL] [Abstract][Full Text] [Related]
5. The human RNA polymerase II-associated factor 1 (hPaf1): a new regulator of cell-cycle progression.
Moniaux N; Nemos C; Deb S; Zhu B; Dornreiter I; Hollingsworth MA; Batra SK
PLoS One; 2009 Sep; 4(9):e7077. PubMed ID: 19771162
[TBL] [Abstract][Full Text] [Related]
6. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II.
Yart A; Gstaiger M; Wirbelauer C; Pecnik M; Anastasiou D; Hess D; Krek W
Mol Cell Biol; 2005 Jun; 25(12):5052-60. PubMed ID: 15923622
[TBL] [Abstract][Full Text] [Related]
7. hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells.
Karmakar S; Seshacharyulu P; Lakshmanan I; Vaz AP; Chugh S; Sheinin YM; Mahapatra S; Batra SK; Ponnusamy MP
Oncotarget; 2017 Feb; 8(9):14806-14820. PubMed ID: 28122356
[TBL] [Abstract][Full Text] [Related]
8. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
Woodard GE; Lin L; Zhang JH; Agarwal SK; Marx SJ; Simonds WF
Oncogene; 2005 Feb; 24(7):1272-6. PubMed ID: 15580289
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA.
Farber LJ; Kort EJ; Wang P; Chen J; Teh BT
Mol Carcinog; 2010 Mar; 49(3):215-23. PubMed ID: 19908240
[TBL] [Abstract][Full Text] [Related]
10. Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function.
Lin L; Czapiga M; Nini L; Zhang JH; Simonds WF
Mol Cancer Res; 2007 Feb; 5(2):183-93. PubMed ID: 17314275
[TBL] [Abstract][Full Text] [Related]
11. The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene.
Lin L; Zhang JH; Panicker LM; Simonds WF
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17420-5. PubMed ID: 18987311
[TBL] [Abstract][Full Text] [Related]
12. Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin.
Hahn MA; Marsh DJ
Oncogene; 2005 Sep; 24(41):6241-8. PubMed ID: 16116486
[TBL] [Abstract][Full Text] [Related]
13. The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis.
Moniaux N; Nemos C; Schmied BM; Chauhan SC; Deb S; Morikane K; Choudhury A; Vanlith M; Sutherlin M; Sikela JM; Hollingsworth MA; Batra SK
Oncogene; 2006 Jun; 25(23):3247-57. PubMed ID: 16491129
[TBL] [Abstract][Full Text] [Related]
14. IFN-gamma up-regulates platelet-activating factor receptor gene expression in human monocytes.
Ouellet S; Müller E; Rola-Pleszczynski M
J Immunol; 1994 May; 152(10):5092-9. PubMed ID: 8176225
[TBL] [Abstract][Full Text] [Related]
15. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
[TBL] [Abstract][Full Text] [Related]
16. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
17. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
18. HRPT2, a tumor suppressor gene for hyperparathyroidism-jaw tumor syndrome.
Wang PF; Tan MH; Zhang C; Morreau H; Teh BT
Horm Metab Res; 2005 Jun; 37(6):380-3. PubMed ID: 16001331
[TBL] [Abstract][Full Text] [Related]
19. Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas.
Juhlin CC; Haglund F; Villablanca A; Forsberg L; Sandelin K; Bränström R; Larsson C; Höög A
Int J Oncol; 2009 Feb; 34(2):481-92. PubMed ID: 19148484
[TBL] [Abstract][Full Text] [Related]
20. Analysis of MUC4 expression in human pancreatic cancer xenografts in immunodeficient mice.
Ansari D; Bauden MP; Sasor A; Gundewar C; Andersson R
Anticancer Res; 2014 Aug; 34(8):3905-10. PubMed ID: 25075011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
